Coronavirus | AstraZeneca resumes COVID-19 vaccine trial after U.K. green light
Published
AstraZeneca announced on Wednesday it had “voluntarily paused” its trial of the vaccine developed alongside Oxford University after the volunteer developed an unexplained illness
Full Article